Innovation brings opportunity. But just as often, it introduces complexity. For life sciences organizations, that is certainly the case. Cell and gene therapies, digital therapeutics, personalized medicine, biomarkers, and the integration of drugs and medical devices have sparked incredible advancements for the industry, but they have also created new challenges when it comes to clinical trials. Our new POV, Next-Generation Clinical Development: Driving success and time-to-market in clinical drug development, explores how life sciences organizations can leverage powerful new digital and data capabilities, as well as new trial designs, to cut clinical development complexity and harness the power of breakthrough innovations. Read our Point of view https://bit.ly/3SKtKT1 #lifesciences #clinicaldevelopment #Innovation #nextgenclinicaldevelopment
Capgemini Life Sciences and Healthcare’s Post
More Relevant Posts
-
The clinical drug development market is teeming with innovation, including cell and gene therapies, digital therapeutics, personalized medicine and biomarkers, and the integration of drugs and medical devices. However, despite these breakthroughs, many life sciences organizations are not able to fully capitalize on the advancements. Does your organization possess the advanced digital and data capabilities to harness the new trial designs and operating models that will increase program efficiency, speed, and access? Read our latest POV 👇https://bit.ly/3SKtKT1 #LifeSciences #ClinicalDevelopment #Innovation #nextgenclinicaldevelopment
To view or add a comment, sign in
-
The clinical drug development market is teeming with innovation, including cell and gene therapies, digital therapeutics, personalized medicine and biomarkers, and the integration of drugs and medical devices. However, despite these breakthroughs, many life sciences organizations are not able to fully capitalize on the advancements. Does your organization possess the advanced digital and data capabilities to harness the new trial designs and operating models that will increase program efficiency, speed, and access? Read our Point of view 👇 https://bit.ly/48ArUK7 #lifesciences #clinicaldevelopment #Innovation #nextgenclinicaldevelopment
To view or add a comment, sign in
-
🌟Join us for an insightful webinar🌟"Optimizing for the Future: Streamlining the Production of T Cell-Based Immunotherapies" Register here: https://lnkd.in/gxS6t9wB 🗓 Date: Wednesday, October 30 🕗 Time: 08:00 PDT / 11:00 EDT / 15:00 GMT / 16:00 CET #CellTherapy #GeneTherapy #Immunotherapy #Webinar #Innovation #Biotech #Healthcare 🎯 Key Takeaways: 1. Understand the significance of closed, automated cell therapy manufacturing workflows supported by modular instruments, enabling flexible process development and cost-efficient scale-up and scale-out. 2. Discover case studies on industry collaborations aimed at scaling, simplifying, and expediting cell therapy manufacturing, including a lentivirus-mediated, 5 to 7-day process for optimizing transduction efficiency in CAR-T production. 3. Learn about a shortened 24-hour, GMP-compliant process to enhance efficiency in CAR-T manufacturing workflows. The field of cell and gene therapy is advancing rapidly, yet manufacturing challenges remain, with current processes being complex, labor-intensive, and susceptible to contamination and errors. In this webinar, industry experts will discuss how closed, automated cell processing systems with validated protocols and GMP-compliant raw materials can address these challenges. Additionally, the importance of strategic industry partnerships in driving innovation and commercialization will be highlighted. Read our Cell Therapy Handbook for more information: https://lnkd.in/gSumucQj
To view or add a comment, sign in
-
-
🌟Join us for an insightful webinar🌟"Optimizing for the Future: Streamlining the Production of T Cell-Based Immunotherapies" Register here: https://lnkd.in/gxS6t9wB 🗓 Date: Wednesday, October 30 🕗 Time: 08:00 PDT / 11:00 EDT / 15:00 GMT / 16:00 CET #CellTherapy #GeneTherapy #Immunotherapy #Webinar #Innovation #Biotech #Healthcare 🎯 Key Takeaways: 1. Understand the significance of closed, automated cell therapy manufacturing workflows supported by modular instruments, enabling flexible process development and cost-efficient scale-up and scale-out. 2. Discover case studies on industry collaborations aimed at scaling, simplifying, and expediting cell therapy manufacturing, including a lentivirus-mediated, 5 to 7-day process for optimizing transduction efficiency in CAR-T production. 3. Learn about a shortened 24-hour, GMP-compliant process to enhance efficiency in CAR-T manufacturing workflows. The field of cell and gene therapy is advancing rapidly, yet manufacturing challenges remain, with current processes being complex, labor-intensive, and susceptible to contamination and errors. In this webinar, industry experts will discuss how closed, automated cell processing systems with validated protocols and GMP-compliant raw materials can address these challenges. Additionally, the importance of strategic industry partnerships in driving innovation and commercialization will be highlighted. Read our Cell Therapy Handbook for more information: https://lnkd.in/gSumucQj
To view or add a comment, sign in
-
-
Technical Sales Specialist Middle East at Thermo Fisher Scientific | Customer centric advocate to make the world healthier, cleaner and safer
🌟Join us for an insightful webinar🌟"Optimizing for the Future: Streamlining the Production of T Cell-Based Immunotherapies" Register here: https://lnkd.in/gxS6t9wB 🗓 Date: Wednesday, October 30 🕗 Time: 08:00 PDT / 11:00 EDT / 15:00 GMT / 16:00 CET #CellTherapy #GeneTherapy #Immunotherapy #Webinar #Innovation #Biotech #Healthcare 🎯 Key Takeaways: 1. Understand the significance of closed, automated cell therapy manufacturing workflows supported by modular instruments, enabling flexible process development and cost-efficient scale-up and scale-out. 2. Discover case studies on industry collaborations aimed at scaling, simplifying, and expediting cell therapy manufacturing, including a lentivirus-mediated, 5 to 7-day process for optimizing transduction efficiency in CAR-T production. 3. Learn about a shortened 24-hour, GMP-compliant process to enhance efficiency in CAR-T manufacturing workflows. The field of cell and gene therapy is advancing rapidly, yet manufacturing challenges remain, with current processes being complex, labor-intensive, and susceptible to contamination and errors. In this webinar, industry experts will discuss how closed, automated cell processing systems with validated protocols and GMP-compliant raw materials can address these challenges. Additionally, the importance of strategic industry partnerships in driving innovation and commercialization will be highlighted. Read our Cell Therapy Handbook for more information: https://lnkd.in/gSumucQj
To view or add a comment, sign in
-
-
🌟Join us for an insightful webinar🌟"Optimizing for the Future: Streamlining the Production of T Cell-Based Immunotherapies" Register here: https://lnkd.in/gxS6t9wB 🗓 Date: Wednesday, October 30 🕗 Time: 08:00 PDT / 11:00 EDT / 15:00 GMT / 16:00 CET #CellTherapy #GeneTherapy #Immunotherapy #Webinar #Innovation #Biotech #Healthcare 🎯 Key Takeaways: 1. Understand the significance of closed, automated cell therapy manufacturing workflows supported by modular instruments, enabling flexible process development and cost-efficient scale-up and scale-out. 2. Discover case studies on industry collaborations aimed at scaling, simplifying, and expediting cell therapy manufacturing, including a lentivirus-mediated, 5 to 7-day process for optimizing transduction efficiency in CAR-T production. 3. Learn about a shortened 24-hour, GMP-compliant process to enhance efficiency in CAR-T manufacturing workflows. The field of cell and gene therapy is advancing rapidly, yet manufacturing challenges remain, with current processes being complex, labor-intensive, and susceptible to contamination and errors. In this webinar, industry experts will discuss how closed, automated cell processing systems with validated protocols and GMP-compliant raw materials can address these challenges. Additionally, the importance of strategic industry partnerships in driving innovation and commercialization will be highlighted. Read our Cell Therapy Handbook for more information: https://lnkd.in/gSumucQj
To view or add a comment, sign in
-
-
🌟Join us for an insightful webinar🌟"Optimizing for the Future: Streamlining the Production of T Cell-Based Immunotherapies" Register here: https://lnkd.in/gxS6t9wB 🗓 Date: Wednesday, October 30 🕗 Time: 08:00 PDT / 11:00 EDT / 15:00 GMT / 16:00 CET #CellTherapy #GeneTherapy #Immunotherapy #Webinar #Innovation #Biotech #Healthcare 🎯 Key Takeaways: 1. Understand the significance of closed, automated cell therapy manufacturing workflows supported by modular instruments, enabling flexible process development and cost-efficient scale-up and scale-out. 2. Discover case studies on industry collaborations aimed at scaling, simplifying, and expediting cell therapy manufacturing, including a lentivirus-mediated, 5 to 7-day process for optimizing transduction efficiency in CAR-T production. 3. Learn about a shortened 24-hour, GMP-compliant process to enhance efficiency in CAR-T manufacturing workflows. The field of cell and gene therapy is advancing rapidly, yet manufacturing challenges remain, with current processes being complex, labor-intensive, and susceptible to contamination and errors. In this webinar, industry experts will discuss how closed, automated cell processing systems with validated protocols and GMP-compliant raw materials can address these challenges. Additionally, the importance of strategic industry partnerships in driving innovation and commercialization will be highlighted. Read our Cell Therapy Handbook for more information: https://lnkd.in/gSumucQj
To view or add a comment, sign in
-
-
🌟Join us for an insightful webinar🌟"Optimizing for the Future: Streamlining the Production of T Cell-Based Immunotherapies" Register here: https://lnkd.in/gxS6t9wB 🗓 Date: Wednesday, October 30 🕗 Time: 08:00 PDT / 11:00 EDT / 15:00 GMT / 16:00 CET #CellTherapy #GeneTherapy #Immunotherapy #Webinar #Innovation #Biotech #Healthcare 🎯 Key Takeaways: 1. Understand the significance of closed, automated cell therapy manufacturing workflows supported by modular instruments, enabling flexible process development and cost-efficient scale-up and scale-out. 2. Discover case studies on industry collaborations aimed at scaling, simplifying, and expediting cell therapy manufacturing, including a lentivirus-mediated, 5 to 7-day process for optimizing transduction efficiency in CAR-T production. 3. Learn about a shortened 24-hour, GMP-compliant process to enhance efficiency in CAR-T manufacturing workflows. The field of cell and gene therapy is advancing rapidly, yet manufacturing challenges remain, with current processes being complex, labor-intensive, and susceptible to contamination and errors. In this webinar, industry experts will discuss how closed, automated cell processing systems with validated protocols and GMP-compliant raw materials can address these challenges. Additionally, the importance of strategic industry partnerships in driving innovation and commercialization will be highlighted. Read our Cell Therapy Handbook for more information: https://lnkd.in/gSumucQj
To view or add a comment, sign in
-
-
🌟Join us for an insightful webinar🌟"Optimizing for the Future: Streamlining the Production of T Cell-Based Immunotherapies" Register here: https://lnkd.in/gxS6t9wB 🗓 Date: Wednesday, October 30 🕗 Time: 08:00 PDT / 11:00 EDT / 15:00 GMT / 16:00 CET #CellTherapy #GeneTherapy #Immunotherapy #Webinar #Innovation #Biotech #Healthcare 🎯 Key Takeaways: 1. Understand the significance of closed, automated cell therapy manufacturing workflows supported by modular instruments, enabling flexible process development and cost-efficient scale-up and scale-out. 2. Discover case studies on industry collaborations aimed at scaling, simplifying, and expediting cell therapy manufacturing, including a lentivirus-mediated, 5 to 7-day process for optimizing transduction efficiency in CAR-T production. 3. Learn about a shortened 24-hour, GMP-compliant process to enhance efficiency in CAR-T manufacturing workflows. The field of cell and gene therapy is advancing rapidly, yet manufacturing challenges remain, with current processes being complex, labor-intensive, and susceptible to contamination and errors. In this webinar, industry experts will discuss how closed, automated cell processing systems with validated protocols and GMP-compliant raw materials can address these challenges. Additionally, the importance of strategic industry partnerships in driving innovation and commercialization will be highlighted. Read our Cell Therapy Handbook for more information: https://lnkd.in/gSumucQj
To view or add a comment, sign in
-
-
🌟Join us for an insightful webinar🌟"Optimizing for the Future: Streamlining the Production of T Cell-Based Immunotherapies" Register here: https://lnkd.in/gxS6t9wB 🗓 Date: Wednesday, October 30 🕗 Time: 08:00 PDT / 11:00 EDT / 15:00 GMT / 16:00 CET #CellTherapy #GeneTherapy #Immunotherapy #Webinar #Innovation #Biotech #Healthcare 🎯 Key Takeaways: 1. Understand the significance of closed, automated cell therapy manufacturing workflows supported by modular instruments, enabling flexible process development and cost-efficient scale-up and scale-out. 2. Discover case studies on industry collaborations aimed at scaling, simplifying, and expediting cell therapy manufacturing, including a lentivirus-mediated, 5 to 7-day process for optimizing transduction efficiency in CAR-T production. 3. Learn about a shortened 24-hour, GMP-compliant process to enhance efficiency in CAR-T manufacturing workflows. The field of cell and gene therapy is advancing rapidly, yet manufacturing challenges remain, with current processes being complex, labor-intensive, and susceptible to contamination and errors. In this webinar, industry experts will discuss how closed, automated cell processing systems with validated protocols and GMP-compliant raw materials can address these challenges. Additionally, the importance of strategic industry partnerships in driving innovation and commercialization will be highlighted. Read our Cell Therapy Handbook for more information: https://lnkd.in/gSumucQj
To view or add a comment, sign in
-